United States · Venture startup

Who invested in Phenomix Sciences

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 11 months ago

Funding summaryUpdated 26 Oct 2026

$2.5Mraised across 1 round since 2025, from 1 source

Latest round
Venture, $2.5MDec 2025
Investors
1
See who backed them

The rounds

  1. Dec 2025
    Venture$2.5M

    Source recordedSEC filing: $2.5M sold, first sale Dec 2025

Founders and team

From Phenomix Sciences's own website: 3 on the team.

  • Mark BagnallChief Executive Officer
  • Liv WilliamsenChief Operating Officer
  • Tim O’ConnorChief Data Scientist

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Phenomix Sciences as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Southeast Minnesota Capital Fund LLCAngel networkPer its own site

Quick answers about Phenomix Sciences

Who invested in Phenomix Sciences?

Phenomix Sciences's investors include National Institutes of Health.

How much has Phenomix Sciences raised?

Phenomix Sciences has raised $2.5M across 1 round since 2025.

When did Phenomix Sciences last raise?

Phenomix Sciences's most recent round was a Venture of $2.5M in Dec 2025.

What was Phenomix Sciences's biggest round?

Its most recent round, $2.5M in Dec 2025, is also its largest on record.

Who backed Phenomix Sciences first?

Phenomix Sciences's first round on record, in Dec 2025, was backed by National Institutes of Health.

What stage is Phenomix Sciences at?

Phenomix Sciences's latest named round is a Venture, in Dec 2025.

Where is Phenomix Sciences based?

Phenomix Sciences is based in the United States.

Companies like Phenomix Sciences

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.